{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:53:43Z","timestamp":1791356023700,"version":"4.3.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jsbmb.2026.107121","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:12:27Z","timestamp":1789427547000},"page":"107121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Aromatase inhibitors as endocrine modulators: From breast cancer therapy to male off-label use and doping practice"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7627-7635","authenticated-orcid":false,"given":"Andrej","family":"Bandura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"\u010eurina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"\u010camb\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-821X","authenticated-orcid":false,"given":"\u0160tefan","family":"Ke\u010dk\u00e9\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.107121_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","article-title":"Aromatase--a brief overview","volume":"64","author":"Simpson","year":"2002","journal-title":"Annu. Rev. Physiol."},{"issue":"4 14","key":"10.1016\/j.jsbmb.2026.107121_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(03)00302-6","article-title":"Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer","volume":"30","author":"Miller","year":"2003","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/092986711794480177","article-title":"Endocrine therapy of breast cancer","volume":"18","author":"Lumachi","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update","volume":"37","author":"Burstein","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/j.1875-9114.1981.tb03557.x","article-title":"Aminoglutethimide: review of pharmacology and clinical use","volume":"1","author":"Santen","year":"1981","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2011.02.001","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"125","author":"Chumsri","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9453","key":"10.1016\/j.jsbmb.2026.107121_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jsbmb.2026.107121_bib8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1470-2045(11)70270-4","article-title":"Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8\u00b71 years median follow-up","volume":"12","author":"Regan","year":"2011","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.jsbmb.2026.107121_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib11","unstructured":"European Medicines Agency. Arimidex (anastrozole): Summary of Product Characteristics [Internet]. European Medicines Agency; 2011. (Assessment Report pursuant to Article 30 of Directive 2001\/83\/EC, as amended). Report EMA\/418072\/2011. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/arimidex-article-30-referral-assessment-report_en.pdf."},{"key":"10.1016\/j.jsbmb.2026.107121_bib12","unstructured":"European Medicines Agency. Femara (letrozole): Summary of Product Characteristics [Internet]. European Medicines Agency; 2012. (Assessment report pursuant to Article 30 of Directive 2001\/83\/EC, as amended). Report EMA\/267448\/2012. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/femara-article-30-referral-assessment-report_en.pdf."},{"key":"10.1016\/j.jsbmb.2026.107121_bib13","unstructured":"Pfizer Europe MA EEIGicines Agency. Aromasin (exemestane): Summary of Product Characteristics [Internet]. Pfizer Europe MA EEIG; 2022 May. Report EMA\/267448\/2012. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/5520\/smpc\/print."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib14","first-page":"360","article-title":"A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility","volume":"22","author":"Del Giudice","year":"2019","journal-title":"Asian J. Androl."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/EJE-07-0663","article-title":"Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism","volume":"158","author":"Loves","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.10.023","article-title":"Aromatase inhibitors for male infertility","volume":"98","author":"Schlegel","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2026.107121_bib17","unstructured":"World Anti-Doping Agency. INTERNATIONAL STANDARD, Prohibited List 2026 [Internet]. 2026. Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026list_en_final_clean_september_2025.pdf."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib19","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.juro.2013.06.010","article-title":"Anabolic steroid induced hypogonadism in young men","volume":"190","author":"Coward","year":"2013","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13011-023-00573-8","article-title":"The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men","volume":"18","author":"Grant","year":"2023","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ejendo\/lvad164","article-title":"Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study","volume":"189","author":"Grant","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"issue":"23","key":"10.1016\/j.jsbmb.2026.107121_bib23","doi-asserted-by":"crossref","first-page":"17734","DOI":"10.1074\/jbc.M110.123711","article-title":"Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1","volume":"285","author":"Sohl","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1 Pt 2","key":"10.1016\/j.jsbmb.2026.107121_bib24","first-page":"468S","article-title":"Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors","volume":"9","author":"Buzdar","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.jsbmb.2026.107121_bib25","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","article-title":"Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione","volume":"249","author":"Thompson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2026.107121_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fphar.2017.00580","article-title":"Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase","volume":"8","author":"Udhane","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.jsbmb.2026.107121_bib27","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1074\/jbc.M807868200","article-title":"Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450","volume":"284","author":"Hamdane","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.106010","article-title":"A review of 18O labelling Studies to probe the mechanism of aromatase (CYP191A)","volume":"216","author":"Akhtar","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2026.107121_bib30","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.107121_bib31","unstructured":"UniProt [Internet]. [cited 2026 May 3]. UniProt. Available from: https:\/\/www.uniprot.org\/uniprotkb\/P11511\/entry."},{"issue":"24","key":"10.1016\/j.jsbmb.2026.107121_bib32","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra023246","article-title":"Aromatase Inhibitors in Breast Cancer","volume":"348","author":"Smith","year":"2003","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.107121_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1249160","article-title":"Aromatase inhibitors: the journey from the state of the art to clinical open questions","volume":"13","author":"Generali","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib34","doi-asserted-by":"crossref","unstructured":"Furman B.L. Aminoglutethimide. xPharm: The Comprehensive Pharmacology Reference. 2007 Jan 1;1\u20134. doi:10.1016\/B978-008055232-3.61212-7.","DOI":"10.1016\/B978-008055232-3.61212-7"},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00262588","article-title":"Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer","volume":"20","author":"Miller","year":"1987","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib36","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1023\/A:1006048722559","article-title":"Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer","volume":"49","author":"L\u00f8nning","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.jsbmb.2026.107121_bib37","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1210\/jc.2003-031279","article-title":"Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males","volume":"88","author":"Mauras","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/jcem-71-5-1349","article-title":"The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition","volume":"71","author":"Kochak","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bjc.1996.94","article-title":"Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers","volume":"73","author":"Yates","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.jsbmb.2026.107121_bib40","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2008-2527","article-title":"Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia","volume":"94","author":"Mauras","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib41","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/1097-0142(197706)39:6<2948::AID-CNCR2820390681>3.0.CO;2-9","article-title":"Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer","volume":"39","author":"Santen","year":"1977","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jsbmb.2026.107121_bib42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0959-8049(94)00281-9","article-title":"Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer","volume":"30A","author":"Dowsett","year":"1994","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00682739","article-title":"Aromatase inhibitors \u2014 mechanisms of steroidal inhibitors","volume":"30","author":"Brueggemeier","year":"1994","journal-title":"Breast Cancer Res. Tr."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jamaoncol.2023.0089","article-title":"Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial","volume":"9","author":"Serrano","year":"2023","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/molpharm.122.000545","article-title":"Inhibition of the Aromatase Enzyme by Exemestane Cysteine Conjugates","volume":"102","author":"Teslenko","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib46","unstructured":"WADA. WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST 2025 [Internet]. Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/2024-09\/2025list_en_final_clean_12_september_2024.pdf."},{"key":"10.1016\/j.jsbmb.2026.107121_bib47","unstructured":"WADA. Summary of Major Modifications and Explanatory Notes, 2026 Prohibited List [Internet]. p. 4. Report In section: S4. Hormone and Metabolic Modulators. Available from: https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026_list_explanatory_note_en_final_september_2025.pdf."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2174\/187152008785133092","article-title":"Natural products as aromatase inhibitors","volume":"8","author":"Balunas","year":"2008","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.jsbmb.2026.107121_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.crfs.2024.100783","article-title":"Nutritional aphrodisiacs: Biochemistry and Pharmacology","volume":"9","author":"Al-Madhagi","year":"2024","journal-title":"Curr. Res. Food Sci."},{"issue":"17","key":"10.1016\/j.jsbmb.2026.107121_bib50","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/0006-2952(86)90481-8","article-title":"Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of alpha-naphthoflavone","volume":"35","author":"Kellis","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.jsbmb.2026.107121_bib51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/np8000255","article-title":"Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity","volume":"71","author":"Balunas","year":"2008","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03557","article-title":"Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme aromatase (CYP19): A systematic review","volume":"6","author":"Balam","year":"2020","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-52-5-897","article-title":"Effects of delta 1-testolactone on the pituitary-testicular axis in oligospermic men","volume":"52","author":"Vigersky","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1439-0272.1984.tb00414.x","article-title":"Estrogens in the feedback regulation of gonadotropin secretion in men: effects of administration of estrogen to agonadal subjects and the antiestrogen tamoxifen and the aromatase inhibitor delta\u2019-testolactone to eugonadal subjects.","volume":"16","author":"Gooren","year":"1984","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1439-0272.1986.tb01741.x","article-title":"Effect of chronic aromatase inhibition by delta 1-testolactone on pituitary-gonadal function in oligozoospermic men","volume":"18","author":"Dony","year":"1986","journal-title":"Andrologia"},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/j.1939-4640.1989.tb00094.x","article-title":"Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover","volume":"10","author":"Clark","year":"1989","journal-title":"J. Androl."},{"issue":"3\u20138","key":"10.1016\/j.jsbmb.2026.107121_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0960-0760(92)90369-T","article-title":"Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male","volume":"41","author":"Bhatnagar","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0960-0760(93)90227-N","article-title":"Pharmacokinetics of 4-hydroxyandrostenedione in man after intramuscular injection of different formulations and the effect of this drug on plasma aromatizable androgens and 17beta-estradiol concentrations","volume":"46","author":"Danza","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.jsbmb.2026.107121_bib59","first-page":"2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib60","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0022-5347(05)66540-8","article-title":"Evidence of a treatable endocrinopathy in infertile men","volume":"165","author":"Pavlovich","year":"2001","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib61","first-page":"2869","article-title":"The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men","volume":"86","author":"Taxel","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2 Pt 1","key":"10.1016\/j.jsbmb.2026.107121_bib62","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00005392-200202000-00038","article-title":"Aromatase inhibitors for male infertility","volume":"167","author":"Raman","year":"2002","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.jsbmb.2026.107121_bib63","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0026-0495(03)00186-0","article-title":"Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone","volume":"52","author":"Zumoff","year":"2003","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib64","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2003-031467","article-title":"Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels","volume":"89","author":"Leder","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1463-1326.2004.00397.x","article-title":"Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism","volume":"7","author":"de Boer","year":"2005","journal-title":"Diabetes Obes. Metab."},{"issue":"10","key":"10.1016\/j.jsbmb.2026.107121_bib66","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1210\/jc.2005-0982","article-title":"Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition","volume":"90","author":"T\u2019Sjoen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jsbmb.2026.107121_bib67","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1210\/jc.2005-2433","article-title":"Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men","volume":"91","author":"Muller","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2026.107121_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1550-2783-4-13","article-title":"Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males","volume":"4","author":"Rohle","year":"2007","journal-title":"J. Int. Soc. Sports Nutr."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1123\/ijsnem.17.1.92","article-title":"Eight weeks of aromatase inhibition using the nutritional supplement Novedex XT: effects in young, eugonadal men","volume":"17","author":"Willoughby","year":"2007","journal-title":"Int. J. Sport. Nutr. Exerc. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2009.05.014","article-title":"Use of the aromatase inhibitor letrozole to treat male infertility","volume":"92","author":"Patry","year":"2009","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2265.2008.03327.x","article-title":"Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Burnett-Bowie","year":"2009","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.fertnstert.2010.09.021","article-title":"The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men","volume":"95","author":"Saylam","year":"2011","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/aja.2011.44","article-title":"Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH","volume":"13","author":"Cavallini","year":"2011","journal-title":"Asian J. Androl."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fertnstert.2012.04.005","article-title":"Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios","volume":"98","author":"Gregoriou","year":"2012","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/and.12122","article-title":"Successful use of aromatase inhibitor letrozole in NOA with an elevated FSH level: a case report","volume":"46","author":"Zhao","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.jsbmb.2026.107121_bib76","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejogrb.2013.11.006","article-title":"Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases","volume":"173","author":"Kyrou","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2026.107121_bib77","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/aja.2013.99","article-title":"Multivariate analysis to predict letrozole efficacy in improving sperm count of non-obstructive azoospermic and cryptozoospermic patients: a pilot study","volume":"15","author":"Cavallini","year":"2013","journal-title":"Asian J. Androl."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib78","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-13-0190","article-title":"Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia","volume":"169","author":"Loves","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.jsbmb.2026.107121_bib79","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jsm.12944","article-title":"A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men","volume":"12","author":"Helo","year":"2015","journal-title":"J. Sex. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/andr.12126","article-title":"Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial","volume":"4","author":"Dias","year":"2016","journal-title":"Andrology"},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib81","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.fertnstert.2016.11.021","article-title":"Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men","volume":"107","author":"Shoshany","year":"2017","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rbmo.2018.09.016","article-title":"Do men with normal testosterone-oestradiol ratios benefit from letrozole for the treatment of male infertility?","volume":"38","author":"Shuling","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jsbmb.2026.107121_bib83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fendo.2020.00277","article-title":"Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects","volume":"11","author":"Colleluori","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12958-020-00591-2","article-title":"Effect of Letrozole on sperm parameters, chromatin status and ROS level in idiopathic Oligo\/Astheno\/Teratozoospermia","volume":"18","author":"Kooshesh","year":"2020","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib85","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.21037\/tau-20-919","article-title":"Efficacy of anastrozole in the treatment of hypogonadal, subfertile men with body mass index \u226525 kg\/m2","volume":"10","author":"Shah","year":"2021","journal-title":"Transl. Androl. Urol."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib86","doi-asserted-by":"crossref","first-page":"e1803","DOI":"10.1210\/clinem\/dgaa860","article-title":"Testicular Testosterone and Estradiol Concentrations and Aromatase Expression in Men with Nonobstructive Azoospermia","volume":"106","author":"Shiraishi","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jsbmb.2026.107121_bib87","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.21037\/tau-22-95","article-title":"The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios","volume":"11","author":"Yang","year":"2022","journal-title":"Transl. Androl. Urol."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib88","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.06.032","article-title":"Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole","volume":"120","author":"Naelitz","year":"2023","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ejendo\/lvad099","article-title":"Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial","volume":"189","author":"Jones","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib90","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/tau-23-454","article-title":"Combination clomiphene citrate and anastrozole duotherapy improves semen parameters in a multi-institutional, retrospective cohort of infertile men","volume":"13","author":"Osadchiy","year":"2024","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib91","doi-asserted-by":"crossref","unstructured":"Bandura A., Furka S., Hromn\u00edkov\u00e1 D., Kalafutov\u00e1 I., Furka D., B\u00f6hmer D. Clomiphene Citrate in off-Label Post-Cycle Therapy: Mechanisms, Efficacy and Diagnostic Challenges in Endocrine Recovery Following Anabolic Steroid Use. Andrology. doi:10.1111\/andr.70306.","DOI":"10.1111\/andr.70306"},{"issue":"9","key":"10.1016\/j.jsbmb.2026.107121_bib92","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/jc.2006-0462","article-title":"men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion","volume":"91","author":"Raven","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9270","key":"10.1016\/j.jsbmb.2026.107121_bib93","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0140-6736(00)04895-9","article-title":"A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial","volume":"357","author":"Wickman","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib94","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2265.2006.02499.x","article-title":"Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty","volume":"64","author":"Hero","year":"2006","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib95","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000251186","article-title":"Role of testosterone\/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men","volume":"83","author":"Cakan","year":"2009","journal-title":"Urol. Int."},{"issue":"7","key":"10.1016\/j.jsbmb.2026.107121_bib96","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ncpendmet0844","article-title":"Treatment of male infertility secondary to morbid obesity","volume":"4","author":"Roth","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jsbmb.2026.107121_bib97","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2008-2527","article-title":"Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia","volume":"94","author":"Mauras","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib98","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2013.06.010","article-title":"Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor","volume":"100","author":"Mehta","year":"2013","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jsm.12320","article-title":"Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion","volume":"11","author":"Mechlin","year":"2014","journal-title":"J. Sex. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bju.14390","article-title":"Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men","volume":"122","author":"Alder","year":"2018","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2352-4642(18)30377-8","article-title":"Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial","volume":"3","author":"Varimo","year":"2019","journal-title":"Lancet Child. Adolesc. Health"},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humrep\/dez231","article-title":"Anti-M\u00fcllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone","volume":"35","author":"Kohva","year":"2020","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.70039","article-title":"Puberty-Promoting Treatment and Psychosocial Well-Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial","volume":"104","author":"Kariola","year":"2026","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib104","first-page":"467","article-title":"Comparison of Effects of Chorionic Gonadotropin Alfa and Anastrozole on Sperm Retrieval Rate in Patients with Non-Mosaic Klinefelter Syndrome Following Microdissection Testicular Sperm Extraction","volume":"61","author":"Pelit","year":"2025","journal-title":"Med. (Kaunas. )"},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cen.14605","article-title":"Serum testosterone and oestradiol predict the growth response during puberty promoting treatment","volume":"96","author":"Huttunen","year":"2022","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib106","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/s12887-024-05301-0","article-title":"Aromatase inhibitors for short stature in male children and adolescents treated with growth hormone: a meta-analysis of randomized controlled trials","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Pediatr."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib107","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/er.2004-0015","article-title":"Aromatase Inhibitors in the Treatment of Breast Cancer","volume":"26","author":"Brueggemeier","year":"2005","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.jsbmb.2026.107121_bib108","first-page":"2089","article-title":"vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib109","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jsbmb.2026.107121_bib110","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.2007.13.9279","article-title":"Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer","volume":"26","author":"Dixon","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2026.107121_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","article-title":"Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG","volume":"7","author":"Hadji","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib112","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1759720X18759291","article-title":"Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis","volume":"10","author":"Tseng","year":"2018","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"12","key":"10.1016\/j.jsbmb.2026.107121_bib113","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/jc.2009-0739","article-title":"Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels","volume":"94","author":"Burnett-Bowie","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib114","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.1.02226","article-title":"Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition","volume":"155","author":"Hero","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/andr.12284","article-title":"Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters","volume":"5","author":"Dias","year":"2017","journal-title":"Andrology"},{"issue":"10","key":"10.1016\/j.jsbmb.2026.107121_bib116","doi-asserted-by":"crossref","first-page":"e3410","DOI":"10.1210\/clinem\/dgaf038","article-title":"Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes","volume":"110","author":"Ahmed","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib117","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1152\/jappl.1965.20.5.1038","article-title":"Effect of an anabolic steroid on physical performance of young men","volume":"20","author":"Fowler","year":"1965","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib118","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/16.1.62","article-title":"A double-blind trial of an anabolic steroid (stanozolol) in the disabled elderly","volume":"16","author":"Lye","year":"1977","journal-title":"Rheumatol. Rehabil."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-115-5-387","article-title":"Effects of anabolic-androgenic steroids on muscular strength","volume":"115","author":"Elashoff","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib120","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1152\/ajpendo.00032.2003","article-title":"Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies","volume":"285","author":"Schroeder","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib121","first-page":"366","article-title":"Effects of androgenic-anabolic steroids on neuromuscular power and body composition","volume":"54","author":"Crist","year":"1983","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"issue":"7988","key":"10.1016\/j.jsbmb.2026.107121_bib122","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0140-6736(76)90001-5","article-title":"Anabolic\u2019 effects of methandienone in men undergoing athletic training","volume":"2","author":"Hervey","year":"1976","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jsbmb.2026.107121_bib124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.57.2.133","article-title":"Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial","volume":"57","author":"Pope","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/sms.13592","article-title":"Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids","volume":"30","author":"Smit","year":"2020","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jcem-68-1-200","article-title":"Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women","volume":"68","author":"Spinder","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2026.107121_bib127","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem-70-4-944","article-title":"Serum gonadotropins and alpha-subunit decline in aging normal postmenopausal women","volume":"70","author":"Kwekkeboom","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2026.107121_bib128","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/jc.2007-2156","article-title":"Inhibition of Luteinizing Hormone Secretion by Testosterone in Men Requires Aromatization for Its Pituitary But Not Its Hypothalamic Effects: Evidence from the Tandem Study of Normal and Gonadotropin-Releasing Hormone-Deficient Men","volume":"93","author":"Pitteloud","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2026.107121_bib129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jcem-59-5-963","article-title":"Effect of Flutamide or Cyproterone Acetate on Pituitary and Testicular Hormones in Normal Men","volume":"59","author":"KNUTH","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2026.107121_bib130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI111417","article-title":"Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man","volume":"74","author":"Veldhuis","year":"1984","journal-title":"J. Clin. Invest."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:30:54Z","timestamp":1791354654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":130,"alternative-id":["S0960076026001871"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107121","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aromatase inhibitors as endocrine modulators: From breast cancer therapy to male off-label use and doping practice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107121"}}